709 related articles for article (PubMed ID: 23235597)
1. Erythropoietin or darbepoetin for patients with cancer.
Tonia T; Mettler A; Robert N; Schwarzer G; Seidenfeld J; Weingart O; Hyde C; Engert A; Bohlius J
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD003407. PubMed ID: 23235597
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin or darbepoetin for patients with cancer.
Bohlius J; Wilson J; Seidenfeld J; Piper M; Schwarzer G; Sandercock J; Trelle S; Weingart O; Bayliss S; Brunskill S; Djulbegovic B; Benett CL; Langensiepen S; Hyde C; Engert E
Cochrane Database Syst Rev; 2006 Jul; (3):CD003407. PubMed ID: 16856007
[TBL] [Abstract][Full Text] [Related]
3. Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease.
Saglimbene VM; Palmer SC; Ruospo M; Natale P; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD009904. PubMed ID: 28782299
[TBL] [Abstract][Full Text] [Related]
4. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.
Palmer SC; Saglimbene V; Mavridis D; Salanti G; Craig JC; Tonelli M; Wiebe N; Strippoli GF
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010590. PubMed ID: 25486075
[TBL] [Abstract][Full Text] [Related]
5. Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis.
Adams A; Scheckel B; Habsaoui A; Haque M; Kuhr K; Monsef I; Bohlius J; Skoetz N
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD012633. PubMed ID: 35724934
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data.
Bohlius J; Schmidlin K; Brillant C; Schwarzer G; Trelle S; Seidenfeld J; Zwahlen M; Clarke MJ; Weingart O; Kluge S; Piper M; Napoli M; Rades D; Steensma D; Djulbegovic B; Fey MF; Ray-Coquard I; Moebus V; Thomas G; Untch M; Schumacher M; Egger M; Engert A
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007303. PubMed ID: 19588423
[TBL] [Abstract][Full Text] [Related]
7. The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents.
Mhaskar R; Wao H; Miladinovic B; Kumar A; Djulbegovic B
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD009624. PubMed ID: 26845108
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin for patients with malignant disease.
Bohlius J; Langensiepen S; Schwarzer G; Seidenfeld J; Piper M; Bennet C; Engert A
Cochrane Database Syst Rev; 2004; (3):CD003407. PubMed ID: 15266483
[TBL] [Abstract][Full Text] [Related]
9. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.
Chung EY; Palmer SC; Saglimbene VM; Craig JC; Tonelli M; Strippoli GF
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD010590. PubMed ID: 36791280
[TBL] [Abstract][Full Text] [Related]
10. Darbepoetin for the anaemia of chronic kidney disease.
Palmer SC; Saglimbene V; Craig JC; Navaneethan SD; Strippoli GF
Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD009297. PubMed ID: 24683046
[TBL] [Abstract][Full Text] [Related]
11. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
Wilson J; Yao GL; Raftery J; Bohlius J; Brunskill S; Sandercock J; Bayliss S; Moss P; Stanworth S; Hyde C
Health Technol Assess; 2007 Apr; 11(13):1-202, iii-iv. PubMed ID: 17408534
[TBL] [Abstract][Full Text] [Related]
12. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Ohlsson A; Aher SM
Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.
Bennett CL; Silver SM; Djulbegovic B; Samaras AT; Blau CA; Gleason KJ; Barnato SE; Elverman KM; Courtney DM; McKoy JM; Edwards BJ; Tigue CC; Raisch DW; Yarnold PR; Dorr DA; Kuzel TM; Tallman MS; Trifilio SM; West DP; Lai SY; Henke M
JAMA; 2008 Feb; 299(8):914-24. PubMed ID: 18314434
[TBL] [Abstract][Full Text] [Related]
14. Harms of off-label erythropoiesis-stimulating agents for critically ill people.
Mesgarpour B; Heidinger BH; Roth D; Schmitz S; Walsh CD; Herkner H
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010969. PubMed ID: 28841235
[TBL] [Abstract][Full Text] [Related]
15. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Aher S; Ohlsson A
Cochrane Database Syst Rev; 2006 Jul; (3):CD004868. PubMed ID: 16856064
[TBL] [Abstract][Full Text] [Related]
16. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Ohlsson A; Aher SM
Cochrane Database Syst Rev; 2012 Sep; (9):CD004863. PubMed ID: 22972076
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis.
Cody JD; Hodson EM
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD003266. PubMed ID: 26790135
[TBL] [Abstract][Full Text] [Related]
18. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Aher SM; Ohlsson A
Cochrane Database Syst Rev; 2014 Apr; (4):CD004868. PubMed ID: 24760628
[TBL] [Abstract][Full Text] [Related]
19. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Aher SM; Ohlsson A
Cochrane Database Syst Rev; 2006 Jul; (3):CD004865. PubMed ID: 16856063
[TBL] [Abstract][Full Text] [Related]
20. American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.
Rizzo JD; Brouwers M; Hurley P; Seidenfeld J; Arcasoy MO; Spivak JL; Bennett CL; Bohlius J; Evanchuk D; Goode MJ; Jakubowski AA; Regan DH; Somerfield MR;
Blood; 2010 Nov; 116(20):4045-59. PubMed ID: 20974674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
